157 related articles for article (PubMed ID: 17709575)
1. Effects of triamcinolone acetonide injections with and without preservative.
Jonas JB
Br J Ophthalmol; 2007 Sep; 91(9):1099-101. PubMed ID: 17709575
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravitreal triamcinolone acetonide injection with and without preservative.
Maia M; Farah ME; Belfort RN; Penha FM; Lima Filho AA; Aggio FB; Belfort R
Br J Ophthalmol; 2007 Sep; 91(9):1122-4. PubMed ID: 17383993
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.
Stepien KE; Eaton AM; Jaffe GJ; Davis JL; Raja J; Feuer W
Retina; 2009 Feb; 29(2):207-13. PubMed ID: 19050670
[TBL] [Abstract][Full Text] [Related]
4. Presumed Sterile Endophthalmitis Afer Intravitreal Triamcinolone (Kenalog)-More Common and Less Benign Than We Thought?
Fong AH; Chan CK
Asia Pac J Ophthalmol (Phila); 2017; 6(1):45-49. PubMed ID: 28161929
[TBL] [Abstract][Full Text] [Related]
5. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
Ho TC
Ophthalmologica; 2006; 220(6):409; author reply 410. PubMed ID: 17095890
[No Abstract] [Full Text] [Related]
6. Sterile endophthalmitis following intravitreal triamcinolone acetonide in July 2010.
Kim M; Yu SY; Kwak HW
Indian J Ophthalmol; 2015 May; 63(5):467-8. PubMed ID: 26139818
[No Abstract] [Full Text] [Related]
7. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
Aggermann T; Stolba U; Brunner S; Binder S
Ophthalmologica; 2006; 220(2):131-3. PubMed ID: 16491037
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide.
Jonisch J; Lai JC; Deramo VA; Flug AJ; Fastenberg DM
Br J Ophthalmol; 2008 Aug; 92(8):1051-4. PubMed ID: 18653598
[TBL] [Abstract][Full Text] [Related]
9. Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis.
Ganapathy PS; Lowder CY; Arepalli S; Baynes K; Li M; Bena J; Srivastava SK
Am J Ophthalmol; 2018 Oct; 194():63-71. PubMed ID: 30053470
[TBL] [Abstract][Full Text] [Related]
10. The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials.
Bhavsar AR; Ip MS; Glassman AR;
Am J Ophthalmol; 2007 Sep; 144(3):454-6. PubMed ID: 17765429
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injection.
Roth DB; Flynn HW
Am J Ophthalmol; 2008 Sep; 146(3):346-347. PubMed ID: 18724979
[No Abstract] [Full Text] [Related]
12. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Lorenzo Carrero J; Pérez Flores I; González Barcia M
Am J Ophthalmol; 2006 Sep; 142(3):529; author reply 529-30. PubMed ID: 16935616
[No Abstract] [Full Text] [Related]
13. Bacterial endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy.
Mitamura Y; Miyano N; Ohtsuka K
Jpn J Ophthalmol; 2005; 49(6):538-539. PubMed ID: 16365807
[No Abstract] [Full Text] [Related]
14. Acute endophthalmitis incidence: intravitreal triamcinolone.
Westfall AC; Osborn A; Kuhl D; Benz MS; Mieler WF; Holz ER
Arch Ophthalmol; 2005 Aug; 123(8):1075-7. PubMed ID: 16087840
[TBL] [Abstract][Full Text] [Related]
15. Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone.
Kube T; Sutter M; Trittler R; Feltgen N; Hansen LL; Agostini HT
Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1385-90. PubMed ID: 16715253
[TBL] [Abstract][Full Text] [Related]
16. A head-tilt test for hypopyon after intravitreal triamcinolone.
Mahajan VB; Folk JC; Boldt HC
Retina; 2009 Apr; 29(4):560-1. PubMed ID: 19092731
[No Abstract] [Full Text] [Related]
17. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.
Nelson ML; Tennant MT; Sivalingam A; Regillo CD; Belmont JB; Martidis A
Retina; 2003 Oct; 23(5):686-91. PubMed ID: 14574256
[TBL] [Abstract][Full Text] [Related]
18. Ocular morbidity associated with intravitreal triamcinolone acetonide.
Konstantopoulos A; Williams CP; Newsom RS; Luff AJ
Eye (Lond); 2007 Mar; 21(3):317-20. PubMed ID: 16710433
[TBL] [Abstract][Full Text] [Related]
19. Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.
Amato JE; Lee DH; Santos BA; Akduman L
Ocul Immunol Inflamm; 2005; 13(2-3):245-7. PubMed ID: 16019686
[TBL] [Abstract][Full Text] [Related]
20. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
